SGLT2 inhibitors are often withheld during AKI. This study found in adults experiencing acute heart failure-associated AKI, exposure to SGLT2 inhibitors was linked to decreased mortality and no delay in renal recovery https://t.co/Z7bpK02LIq
@fperrywilson@dmoledina@Nephronette